sentavio-shutterstock-com-1

Sentavio / Shutterstock.com

15 June 2016Big Pharma

Optimising IP strategies: Life Sciences Law Forum preview

The fourth annual Life Sciences Law Forum, hosted by Thomson Reuters, aims to focus on equipping lawyers with practical solutions and strategies for addressing the challenges their organisation may face throughout a product’s lifecycle.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Sandoz wins $137.2m payout for lost profits in generic launch

Dexcom suffers second patent revocation at hands of UPC

Sanofi signs global rights deal to develop rare cancer therapy

Novo Nordisk files fresh lawsuits to intercept Wegovy generics

AstraZeneca unit draws line under Samsung dispute

Does the UPC offer a fresh take on patent validity?

Regeneron targets almost 50 patents in suit against Sandoz